EFBEMALENOGRASTIM ALFA Pharmacologic Class Indexing
- Class set ID
- cb2902e5-5514-4e7e-888f-6b29899c2118
- Version
- 1
- Effective date
- 20231204
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use RYZNEUTA ®safely and effectively. See full prescribing information for RYZNEUTA. RYZNEUTA ®(efbemalenograstim alfa-vuxw) injection, for subcutaneous use Initial U.S. Approval: 2023 | Acrotech Biopharma Inc | Evive Biotechnology Singapore PTE. LTD. | PCI San Diego, Inc. | Eurofins Lancaster Laboratories, Inc. | FUJIFILM Diosynth Biotechnologies U.S.A., Inc | Catalent Germany Schorndorf GmbH | WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd. | Evive Biopharmaceutical (Beijing) LTD | 20260519 | 7 |